ClinVar Miner

Submissions for variant NM_001035.3(RYR2):c.4068C>T (p.Pro1356=)

gnomAD frequency: 0.00240  dbSNP: rs199821105
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000036739 SCV000060394 likely benign not specified 2012-02-07 criteria provided, single submitter clinical testing Pro1356Pro in exon 31 of RYR2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. This variant has been identified in 1/6652 Eu ropean American chromosomes by the NHLBI Exome Sequencing Project in a broad pop ulation (http://evs.gs.washington.edu/EVS). Pro1356Pro in exon 31 of RYR2 (alle le frequency = 1/6652) **
Illumina Laboratory Services, Illumina RCV000405365 SCV000356275 uncertain significance Arrhythmogenic right ventricular dysplasia 2 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Illumina Laboratory Services, Illumina RCV001093761 SCV000356276 likely benign Catecholaminergic polymorphic ventricular tachycardia 1 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.
GeneDx RCV001719733 SCV000514442 benign not provided 2021-04-30 criteria provided, single submitter clinical testing
Invitae RCV001093761 SCV000760743 benign Catecholaminergic polymorphic ventricular tachycardia 1 2024-01-28 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV001189398 SCV001356682 benign Cardiomyopathy 2018-03-16 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV001719733 SCV002497001 benign not provided 2022-04-01 criteria provided, single submitter clinical testing RYR2: BS1, BS2
Ambry Genetics RCV002321507 SCV002626432 benign Cardiovascular phenotype 2018-08-24 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.